Showing 1 - 20 results of 31 for search 'T. Illidge', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Correction: Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study. by Tamara Prinsenberg, Joël Illidge, Paul Zantkuijl, Maarten Bedert, Maria Prins, Marc van de R Valk, Udi Davidovich
Published 2023-01-01
Article -
9
-
10
Methodological considerations in the evaluation of radiotherapy technologies. by Burnet, N, Billingham, L, Chan, C, Hall, E, Macdougall, J, Mackay, R, Maughan, T, Nutting, C, Staffurth, J, Illidge, T
Published 2012Journal article -
11
Methodological Considerations in the Evaluation of Radiotherapy Technologies by Burnet, N, Billingham, L, Chan, C, Hall, E, Macdougall, J, Mackay, R, Maughan, T, Nutting, C, Staffurth, J, Illidge, T
Published 2012Journal article -
12
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer by Vicky Smith, Dave Lee, Mark Reardon, Rekaya Shabbir, Sudhakar Sahoo, Peter Hoskin, Ananya Choudhury, Timothy Illidge, Catharine M. L. West
Published 2023-05-01
Article -
13
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer by Vicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, Alexander Baker, Hitesh Mistry, Ananya Choudhury, Peter Hoskin, Timothy Illidge, Catharine M. L. West
Published 2022-12-01
Article -
14
Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breas... by Gentilini MV, Doeyo M, Ortega M, Illidge Perez L, Rumbo C, Arriola Benitez PC, Crivelli A, Rumbo M, Solar H, Gondolesi GE
Published 2022-11-01
Article -
15
Predicted risks of cardiovascular disease following chemotherapy and radiotherapy in the UK NCRI RAPID trial of positron emission tomography–directed therapy for early-stage Hodgki... by Cutter, DJ, Ramroth, J, Diez, P, Buckle, A, Ntentas, G, Popova, B, Clifton-Hadley, L, Hoskin, PJ, Darby, SC, Radford, J, Illidge, T
Published 2021Journal article -
16
P1130: FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PH... by Swaminathan Iyer, Deepa Jagadeesh, Eva Domingo Domènech, Fabio Benedetti, Antonia Rodriguez Izquierdo, Kamal Bouabdallah, Umberto Vitolo, Tim Illidge, Jingmin Liu, Scott Knowles, Steven Horwitz
Published 2023-08-01
Article -
17
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. by Oscier, D, Dearden, C, Eren, E, Erem, E, Fegan, C, Follows, G, Hillmen, P, Illidge, T, Matutes, E, Milligan, D, Pettitt, A, Schuh, A, Wimperis, J
Published 2012Journal article -
18
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies by Ester Fagnano, Swati Pendharkar, Madyson Colton, Philip N. Jones, Marta Crespi Sallan, Tetyana Klymenko, Andrejs Braun, Christian Klein, Jamie Honeychurch, Eleanor J. Cheadle, Timothy M. Illidge
Published 2023-10-01
Article -
19
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. by Harrington, K, Billingham, L, Brunner, T, Burnet, N, Chan, C, Hoskin, P, Mackay, R, Maughan, T, Macdougall, J, Mckenna, W, Nutting, C, Oliver, A, Plummer, R, Stratford, I, Illidge, T
Published 2011Journal article -
20
Radiotherapy research priorities for the UK. by Maughan, T, Illidge, T, Hoskin, P, Mckenna, W, Brunner, T, Stratford, I, Harrington, K, Plummer, R, Billingham, L, Nutting, C, Burnet, N, Mackay, R, Oliver, A, Young, C, Chan, C
Published 2010Journal article